Biotech company Ocugen has started the ArMaDa Phase 1/2 clinical trial of OCU410, a modfier gene therapy product candidate being developed for dry age-related macular degeneration.

The Primary Care Physician Scholarship program is educating a new generation of doctors, reducing debt and providing a path to practice in Arizona.

Victoria Maizes, MD, executive director of the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson, is interviewed about topics including coping with holiday stress.

UArizona Health Sciences has selected the design-build team of McCarthy + SmithGroup to develop the Center for Advanced Molecular and Immunological Therapies, or CAMI.

Pfizer's stock dropped more than 44% in 2023, partly because fewer people than expected opted to receive COVID-19 booster shots.

Arizona Sens. Mark Kelly and Kyrsten Sinema and Rep. David Schweikert, introduced the Finding Orphan-disease Remedies with Antifungal Research and Development Act, which supports research initiatives to combat Valley fever.

Dr. Julie Pilitsis joins the Department of Neurosurgery and Banner Neurosciences on Jan. 8.

All of Us Research Program University of Arizona-Banner Health

A study published in Progress in Neurobiology and led by College of Medicine – Tucson researchers has developed an improved method to study Parkinson’s disease in the lab.